London, K.S.; Durney, P.; Warrick-Stone, T.; Alexander, K.; Kahoud, J.L.
Decreased Effectiveness of a Novel Opioid Withdrawal Protocol Following the Emergence of Medetomidine as a Fentanyl Adulterant. BioMed 2025, 5, 13.
https://doi.org/10.3390/biomed5020013
AMA Style
London KS, Durney P, Warrick-Stone T, Alexander K, Kahoud JL.
Decreased Effectiveness of a Novel Opioid Withdrawal Protocol Following the Emergence of Medetomidine as a Fentanyl Adulterant. BioMed. 2025; 5(2):13.
https://doi.org/10.3390/biomed5020013
Chicago/Turabian Style
London, Kory S., Philip Durney, TaReva Warrick-Stone, Karen Alexander, and Jennifer L. Kahoud.
2025. "Decreased Effectiveness of a Novel Opioid Withdrawal Protocol Following the Emergence of Medetomidine as a Fentanyl Adulterant" BioMed 5, no. 2: 13.
https://doi.org/10.3390/biomed5020013
APA Style
London, K. S., Durney, P., Warrick-Stone, T., Alexander, K., & Kahoud, J. L.
(2025). Decreased Effectiveness of a Novel Opioid Withdrawal Protocol Following the Emergence of Medetomidine as a Fentanyl Adulterant. BioMed, 5(2), 13.
https://doi.org/10.3390/biomed5020013